Increased levels of plasma VWF during pregnancy or infection, which are common clinical triggers of acquired TTP, might lead to substrate‐induced activation of ADAMTS‐13 and antigenic exposure. The gene discussed is VWF; the disease is thrombotic thrombocytopenic purpura.